Easing the bottleneck

Pharmaceutical Technology

Volumn 33, Issue 5, 2009, Pages 44-50

  Hoffman, Michelle ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CELL PROTEIN; DNA; LIGAND; MONOCLONAL ANTIBODY; NUCLEIC ACID; PROTEIN A; RESIN; RITUXIMAB; RNA;

ANIMAL CELL; ARTHRITIS; BACTERIAL CELL WALL; BIOREACTOR; BIOTECHNOLOGY; CANCER IMMUNOTHERAPY; CELL CULTURE; CELL METABOLISM; CULTURE MEDIUM; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; GENETIC ENGINEERING; HUMAN; MAMMAL CELL; NEOPLASM; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PURIFICATION; REVIEW; STAPHYLOCOCCUS AUREUS; VIRAL CONTAMINATION;

EID: 67650074222     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. F. Detmers, P. Hermans, and M. Ten Hafft, "Affinity Chromatography Based upon Unique Single Chain Antibodies," LCGC The Peak, Sept.2007.
2. G. Jagschies, "Where Is Biopharmaceutical Manufacturing Heading?," BioPharm Inter., 21 (10), 72-88(2008).
3. L. Giovannoni, M. Ventani, and U. Gottschalk, "Antibody Purification Using Membrane Adsorbers," BioPharrn Inter., 21(12), 48-52(2008).
4. U. Gottschalk, Ed., Process Scale Purification of Antibodies (John Wiley & Sons, 2009).
5. U. Gottschallc, "Downstream Processing of Monoclonal Antibodies: From High Dilution to High Purity," BioPharrn Inter., 19(6), (2005).
6. M. Rios, "Eluting Possibilities with Mixed- Mode Chromatography," Pharm. Technol. 31 (5) 40-48 (2007).